Disease Complexity and Nodule-Specific Responses to Atezolizumab plus Bevacizumab in Advanced Hepatocellular Carcinoma

Sae Yumita, Sadahisa Ogasawara, Makoto Fujiya, Teppei Akatsuka, Ryo Izai, Keiichi Katayama, Midori Sawada, Takahiro Tsuchiya, Chihiro Miwa, Ryohei Yoshino, Takuya Yonemoto, Hiroaki Kanzaki, Keisuke Koroki, Masanori Inoue, Kazufumi Kobayashi, Masato Nakamura, Naoya Kanogawa, Shingo Nakamoto, Kengo Nagashima, Jun Kato

Open source

DOI: 10.1159/000548537
Published: 2025-09-22
Container: Liver Cancer
Publisher: S. Karger AG
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1159/000548537,
  title = {Disease Complexity and Nodule-Specific Responses to Atezolizumab plus Bevacizumab in Advanced Hepatocellular Carcinoma},
  author = {Sae Yumita and Sadahisa Ogasawara and Makoto Fujiya and Teppei Akatsuka and Ryo Izai and Keiichi Katayama and Midori Sawada and Takahiro Tsuchiya and Chihiro Miwa and Ryohei Yoshino and Takuya Yonemoto and Hiroaki Kanzaki and Keisuke Koroki and Masanori Inoue and Kazufumi Kobayashi and Masato Nakamura and Naoya Kanogawa and Shingo Nakamoto and Kengo Nagashima and Jun Kato},
  year = {2025},
  journal = {Liver Cancer},
  doi = {10.1159/000548537},
  url = {https://doi.org/10.1159/000548537}
}

RIS

TY  - JOUR
TI  - Disease Complexity and Nodule-Specific Responses to Atezolizumab plus Bevacizumab in Advanced Hepatocellular Carcinoma
AU  - Sae Yumita
AU  - Sadahisa Ogasawara
AU  - Makoto Fujiya
AU  - Teppei Akatsuka
AU  - Ryo Izai
AU  - Keiichi Katayama
AU  - Midori Sawada
AU  - Takahiro Tsuchiya
AU  - Chihiro Miwa
AU  - Ryohei Yoshino
AU  - Takuya Yonemoto
AU  - Hiroaki Kanzaki
AU  - Keisuke Koroki
AU  - Masanori Inoue
AU  - Kazufumi Kobayashi
AU  - Masato Nakamura
AU  - Naoya Kanogawa
AU  - Shingo Nakamoto
AU  - Kengo Nagashima
AU  - Jun Kato
PY  - 2025
JO  - Liver Cancer
DO  - 10.1159/000548537
UR  - https://doi.org/10.1159/000548537
ER  -

APA

Yumita, S., Ogasawara, S., Fujiya, M., Akatsuka, T., Izai, R., Katayama, K., Sawada, M., Tsuchiya, T., Miwa, C., Yoshino, R., Yonemoto, T., Kanzaki, H., Koroki, K., Inoue, M., Kobayashi, K., Nakamura, M., Kanogawa, N., Nakamoto, S., Nagashima, K., & Kato, J. (2025). Disease Complexity and Nodule-Specific Responses to Atezolizumab plus Bevacizumab in Advanced Hepatocellular Carcinoma. Liver Cancer. https://doi.org/10.1159/000548537

Source records

crossref · retrieved 2026-09-26T16:10:26.606Z